|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- Inalta concentratie de oxigen reactiv - radicalii liberi si cantitatea insuficienta in organism de antioxidanti, genera in organite (centrale energetice celulare) eficacitatea scazuta a repararii ADN-ului, ca rezultat: Disfunctia mitocondriala, care este o caracteristica a celulelor maligne.31
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L-Lizina reduce ateroscleroza prin modificarea de lipoproteina(a) = apoa.
| Radicalii liberi produc stres oxidativ | Distrugerile ADN-ului de radicalii liberi care produc stres oxidativ |
 |
 |
- Mutatiile ADN-ului de radicalii liberi afecteaza energia celulara ATP Administrarea de antioxidanti ca factor anti cancer determina reversia fenotipului malign prin inhibarea celulelor de cancer - Anti cancer: EGCG Galatul de epigalocatechina
| Degradarea ADN-ului prin acumularea de 8-hidroxi-2’-deoxiguanozina | Reversia fenotipului malign prin inhibarea celulelor de cancer |
 |
 |
Neutralizarea de radicali liberi - Densitatea antioxidativa
Despre antioxidanti: Antioxidantii sint molecule
care apara organismul de efectele oxigenului reactiv - Radicalii liberi
Radicalii liberi produc stres oxidativ, iar antioxidantii apara celula de radicalii
liberi care sint molecule instabile, contin electroni neimperecheati, adica
un electron ocupa un singur orbital.
32
Vitaminele cu activitate antioxidanta de neutralizare de radicali liberi si bolile cardiovasculare
Disfunctia mitocondriala care este o caracteristica a celulelor maligne, datorat prin capacitatea scazuta antioxidativa.
| Antioxidantii apara celula de efectele oxigenului reactiv | Antioxidantii cu neutralizarea de radicali liberi - Capacitate scazuta antioxidativa |
 |
 |
- Antioxidanti se gasesc in orice celula, protejeaza organismul de distrugerile
provocate la nivel celular de radicalii liberi.
- Antioxidantii pot neutraliza radicalii liberi limitind distrugerea provocata,
daca suficienti antioxidanti sint involvati - Capacitate suficienta antioxidativa
- Acid Alfa Lipoic prin proprietati si functie regenereaza alti antioxidanti
ca: Vitamina C, Vitamina E, Glutation, Coenzima Q10 ofera protectie antioxidativa
de efectele radicalilor liberi.
Antioxidantii protejind celula de radicalii liberi - Capacitate suficienta
34 Vitamina C inbunatateste endoteliul - dependent de vasodilatatie
la restaurarea oxidului nitric si esential la hipertensiune
Vitamina C inbunatateste endoteliul - dependent de vasodilatatie la restaurarea oxidului nitric si esential la hipertensiune
35 Vitamina C inbunatateste circulatia singelui
Studiu vasodilator: Vasodilatatia creste calibrul vaselor, regleaza circulatia sanguina, scade tensiunea arteriala, foarte important la hipertensiune, sportivi, atleti sau persoane care doresc sa-si mentina vitalitatea
36 Efectul
de Vitamina C cu Acid Ascorbic in circulatia singelui la fumatori
37 Vitamina C inbunatateste activitatea cardiovasculara si microcirculatia
la fumatori
38 Cine fumeaza trebuie sa isi asigure aportul de Vitamina C care previne
producerea daunei oxidative prin radicalii liberi, cauzata de fumat
Cine fumeaza trebuie sa isi asigure aportul de Vitamina C care previne producerea daunei oxidative prin radicalii liberi, cauzata de fumat
39 Vitamina C la infectiile acute respiratorii
Vitamina C la infectia acuta respiratorie
40 Vitamina
C cu Acid Ascorbic cu efect la histamina bronhiilor, pacientiilor cu rinita alergica
41 Vitamina
C cu Acid Ascorbic un raspuns cutanal si nasal la histamina si alergie
Vitamina C cu Acid Ascorbic 4 g pe zi un raspuns cutanal si nasal la histamina si alergie
42 Suplimente nutritive cu Vitamina C ca suport la boala de cancer
si prelungirea supravietuirii umane la cancer
L-Lizina inhiba colagenaza care descompune colagenul si favorizeaza cresterea celulelor de cancer
L-Lizina inhiba colagenaza care descompune colagenul si favorizeaza metastaza canceroasa
43 Vitamina C cu doza inalta in tratamentul pacientilor
de cancer unde nu are prioritate citostaticele, studiu randomizat, dublu-orb,
placebo controlat
44 Vitamina C cu doza inalta in tratamentul helicobacter
pylori
45 Vitamina C - Farmacocinetica la implicarea folosirii
orale si intravenoase
46 Vitamina C inhiba cresterea bacteriala de helicobacter
pylori, factor cu risc la cancerul gastric
47 Interactiune intre Vitamina C si Seleniu inhiba cresterea
cancerului mamar
48 Vitamina
C inbunatateste activitatea la doxorubicina, cisplatin si paclitaxel in
cancerul mamar
49 Vitamina C imunomodulator la infectia celulara HIV
| Control Oftamologic | Pentru o vedere oculara mai buna |
 |
 |
50 Vitamina C pe durata lunga previne cataracta
cu cristalin opac
51 Vitamina
C si Vitamina E 400 U I la cataracta persoanelor in virsta cu periclitare
de pierderea vederii, studiu randomizat dublu-orb placebo controlat
| Cataracta cu cristalin opac | Cataracta un rezultat al procesului de imbatrinire... |
 |
 |
52 Vitamina C previne cataracta la persoanele in
virsta
| Pacientul acopera un ochi si priveste punctul daca vederea devine ondulatorie poate fi caz de degenerescenta maculara. | Degenerescenta maculara |
 |
 |
53 Vitamina C cu potential efect preventiv de
degenerescenta maculara (AMD)
54 O portocala pe zi tii pe doctor departe
O portocala pe zi, tii pe doctor departe - Suplimente nutritive cu Vitamina C
55 Vitamina C referinte de administrare
Terapia Anti Aging:
Anti-Aging-Systeme
- Formula AntiAging
| Bibliografie-Referinte: |
 |
| Informatii din bibliografia electronica la tema: Nutritie si sanatate |
1
Boonmark NW, Lou XJ,
Yang ZJ, Schwartz K, Zhang JL, Rubin EM, Lawn RM. Modification
of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic
mice. Falk Cardiovascular Research Center, Stanford University School of
Medicine, Stanford, California 94305-5246, USA.J Clin Invest. 1997 Aug
1;100(3):558-64.
2 Griffith RS, Walsh DE, Myrmel KH, Thompson
RW, Behforooz A. Success
of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment
and prophylaxis. Department of Medicine, Indiana University School of Medicine,
Indianapolis. Dermatologica.
1987;175(4):183-90.
-Griffith RS, De Long DC,
Nelson JD. Relation of L-arginine—lysine antagonism to herpes simplex
growth in tissue culture. Chemotherapy. 1981; 27:209-213.
-
McCune MA, Perry HO, Muller SA, O'Fallon WM. Treatment
of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis.
1984 Oct;34(4):366-73.
3 Di Giovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes
simplex
infection. Treatment and prophylaxis. Arch Dermatol. 1984 Jan;120(1):48-51.
4 Krymchantowski AV, Barbosa JS, Cheim C, Alves LA. Oral
lysine clonixinate in the acute treatment of migraine: a double-blind placebo-controlled
study. Headache Center of Rio, Rio de Janeiro, Brazil. Arq Neuropsiquiatr.
2001 Mar;59(1):46-9.
5 Rath M, Pauling L. Immunological
evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion
of the hypoascorbemic guinea pig. Linus Pauling Institute of Science and
Medicine, Palo Alto, CA 94306-2025. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9388-90.
6 Stubbs P, Seed M, Moseley D, O'Connor
B, Collinson P, Noble M. A
prospective study of the role of lipoprotein(a) in the pathogenesis of unstable
angina. Charing Cross and Westminster Medical School, London, U.K. Eur
Heart
J. 1997 Apr;18(4):603-7.
7 Pauling L. Case Report: Lysine/Ascorbate-related
Amelioration
of Angina Pectoris. J Orthomolecular Med. 1991;6:144-46.
8 Griffith RS, Norins AL, Kagan
C. A
multicentered study of lysine therapy
in Herpes simplex infection. Dermatologica. 1978;156(5):257-67.
- Kagan, C. "Lysine Therapy for Herpes Simplex",
The Lancet, 1:137
26 Jan 1974
9 Thein DJ, Hurt WC. Lysine
as a prophylactic agent in the treatment of recurrent herpes simplex labialis.
Oral Surg Oral Med Oral Pathol. 1984 Dec;58(6):659-66.
10 Furst P. Dietary
L-Lysine supplementation; a promising nutritional tool in the prophylaxis and
treatment of osteoporosis. Nutrition. 1993 Jan-Feb;9(1):71-2.
11 Civitelli R, Villareal DT, Agnusdei
D, Nardi P, Avioli LV, Gennari C. Dietary
L-lysine and calcium metabolism in humans. Institute of Medical Pathology,
University
of Siena, Italy. Nutrition. 1992 Nov-Dec;8(6):400-5.
12 Flondin NW. The metabolic roles,
pharmacology, and toxicology of lysine. J Am Coll Nutr. 1997; 16:7-21.
13 Rajamohan
T, Kurup PA. Lysine: arginine ratio of a protein influences cholesterol metabolism.
Part 1--Studies
on sesame protein having low lysine: arginine ratio. Department of Biochemistry,
University of Kerala Kariavattom, Thiruvananthapuram, India. Indian J Exp Biol.
1997 Nov;35(11):1218-23.
14 Pauling L. Evolution and the need for ascorbic acid. Proc Natl Acad SciUSA.
1970; 67:1643-1648.
15 Pauling L. The
significance of the evidence about ascorbic acid and the common cold. Proc
Natl Acad SciUSA. 1971; 68:2678-2681.
- Douglas RM, Hemila H, D'Souza R, Chalker EB, Treacy B. Vitamin
C for preventing
and treating the common cold. National Centre for Epidemiology and Population
Health, Australian National University, 34 Nungara Place, Aranda, ACT, Australia,
2614. Cochrane Database
Syst Rev. 2004 Oct 18;(4):CD000980.
- Pauling LC. Vitamin
C and the Common Cold. San Francisco: W. H. Freeman; 1970.
16 Cooke MS, Evans MD, Podmore ID, et al. Novel repair action of vitamin C upon
in vivo oxidative DNA damage. FEBS
Lett. 1998; 439:363-367.
- Rehman A, Collis CS, Yang M, et al. The effects of iron and vitamin C co-supplementation
on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun.
1998; 246:293-298.
17 Friedman PA, Zeidel ML. Victory
at C. Nature Med. 1999; 5:620-621.
18 Levine M, Rumsey SC, Daruwala R, Park
JB, Wang Y. Criteria
and recommendations
for vitamin C intake. Molecular and Clinical Nutrition Section, Digestive Diseases
Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National
Institutes
of Health, Bethesda, MD 20892, USA. JAMA. 1999 Apr 21;281(15):1415-23.
19 Rowe DJ, Ko S, Tom XM, Silverstein SJ, Richards DW. Enhanced
production of mineralized nodules and collagenous proteins in vitro by calcium
ascorbate
supplemented with vitamin C metabolites. Department of Dental Public Health and
Hygiene, School of Dentistry, University of California, San Francisco 94143-0754,
USA. djrowe@itsa.ucsf.edu J Periodontol.
1999 Sep;70(9):992-9.
20 Ginter E 1977. the Role of Vitamin C and Cholesterol, in Re-evaluation of
Vitamin C Hrsg. A. Hanck und G. Ritzel, H. Huber, Bern S. 53-56
- Fidanza, A. et al. Vitamin C and cholesterol. Int. J. Vit. Nutr. Res. 1982;
23:153-171.
21 Carr AC, Frei B. Toward
a new recommended dietary allowance for vitamin C based on antioxidant and health
effects in humans. Linus Pauling Institute, Oregon State University, Corvallis
97331, USA. Am J
Clin Nutr. 1999 Jun;69(6):1086-107.
- Levine M, Wang Y, Padayatty
SJ, Morrow J. A
new recommended dietary allowance of vitamin C for healthy young women. Molecular
and Clinical Nutrition Section, Digestive Diseases Branch, National Institute
of Diabetes and Digestive and Kidney Diseases, National Institutes
of Health, Bethesda, MD 20892-1372, USA. markl@intra.niddk.nih.gov Proc Natl
Acad Sci U
S A. 2001 Aug 14;98(17):9842-6.
22 Ginter E, Cerna O, Budlovsky J, Balaz V, Hruba F, Roch V, Sasko E. Effect
of ascorbic acid on plasma cholesterol in humans in a long-term experiment. Int
J Vitam Nutr Res. 1977;47(2):123-34.
- Hornig, D., Weiser, H. Ascorbic
acid and cholesterol: effect of graded oral intakes on cholesterol conversion
to bile acid in guinea-pigs. Experientia. 1976 Jun 15;32(6):687-9.
23 Hwang J, Peterson H, Hodis HN, Choi B, Sevanian A. Ascorbic
acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein
formation. Department of Molecular Pharmacology and Toxicology, School of Pharmacy,
University of Southern California, 1985 Zonal Avenue, PSC 612, 90033, Los Angeles,
CA, USA.
julianah@hsc.usc.edu Atherosclerosis. 2000 Jun;150(2):275-84.
- Jialal, I., Fuller, C.J. Effect of vitamin E, Vitamin C and beta-carotene on
LDL oxidation and atherosclerosis. Canad. J. Cardiol. 1995; 11, (Suppl G): 97-103.
24 Valkonen MM, Kuusi T. Vitamin
C prevents the acute atherogenic effects of
passive smoking. Department of Medicine, University of Helsinki, Helsinki, Finland.
Free Radic
Biol Med. 2000 Feb 1;28(3):428-36.
25 Yokoyama T, Date C, Kokubo Y, Yoshiike
N, Matsumura Y, Tanaka H. Serum
vitamin C concentration was inversely associated with subsequent 20-year incidence
of stroke in a Japanese rural community. The Shibata study. Department of Epidemiology,
Medical Research Institute, Tokyo
Medical and Dental University,
Tokyo, Japan.
Stroke. 2000 Oct;31(10):2287-94.
26 Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, Manson JE, Willett
WC. Vitamin
C and risk of coronary heart disease in women. Department of Medicine, Children's
Hospital, Boston, Massachusetts, USA. stavroula.osganian@TCH.harvard.edu
J Am
Coll Cardiol. 2003 Jul 16;42(2):246-52.
- Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, Goldbourt
U, Heitmann BL, Hallmans G, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo
J, Willett WC, Rimm EB, Ascherio A. Antioxidant
vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. National
Public Health Institute, Helsinki, Finland. paul.knekt@ktl.fi Am J
Clin
Nutr. 2004 Dec;80(6):1508-20.
27 Losonczy KG, Harris TB, Havlik RJ. Vitamin
E and vitamin C supplement use and risk of all-cause and coronary heart disease
mortality in older persons: the Established Populations for Epidemiologic Studies
of the Elderly. Epidemiology, Demography and Biometry Program, National Institute
on Aging, Bethesda, MD 20892-9205,
USA. klosoncz@gibbs.oit.unc.edu
Am J Clin Nutr. 1996 Aug;64(2):190-6.
28 Gokce N, Keaney JF Jr, Frei B, Holbrook M, Olesiak M, Zachariah BJ, Leeuwenburgh
C, Heinecke JW, Vita JA. Long-term
ascorbic acid administration reverses endothelial vasomotor dysfunction in patients
with coronary artery disease. Evans Memorial Department of Medicine, Cardiology
Section, and Whitaker Cardiovascular Institute, Boston University School of Medicine,
Boston, MA, USA. Circulation.
1999 Jun 29;99(25):3234-40.
29 Collins R, Peto R, Armitage J. The
MRC/BHF Heart Protection Study: preliminary
results. Oxford Clinical Trials Service Unit. Int J Clin Pract. 2002 Jan-Feb;56(1):53-6.
30 Beckman,
K. & Ames, B. (1998) "The
free radical theory of aging matures" Physiol Rev 78: 548-81
31 Chamiec, T., Herbaczynska-Cedro, K., Ceremuzynski,
L. Effects of antioxidant vitamin C and E on signal-averaged electrocardiogram
in acute myocardial infarction
Am.
J. Cardiol.1996; 77, 4: 237-241.
32 Jha, P., et al., "The Antioxidant Vitamins
and Cadiovascular Disease," Ann. Of Intern. Med., vol. 123 (1995), pp. 860.
33 Duffy SJ, Gokce N, Holbrook M, Huang
A, Frei B, Keaney JF Jr, Vita JA. Treatment
of hypertension with ascorbic acid.
Lancet. 1999 Dec 11;354(9195):2048-9.
-
Ness AR, Chee D, Elliot P. Vitamin C and blood pressure—an
overview. J
Hum Hypertens. 1997; 11:343-350.
34 Taddei S, Virdis A, Ghiadoni L, et al. Vitamin C improves endothelium-dependent
vasodilation by restoring nitric oxide activity in essential hypertension.
Circulation. 1998; 97:2222-2229.
35 Simon
JA, Hudes ES. Relationship
of ascorbic acid to blood lead levels. Department of Epidemiology and Biostatistics,
University of California, Veterans Affairs Medical Center, San Francisco 94121,
USA. jasimon@itsa.ucsf.edu JAMA.
1999 Jun
23-30;281(24):2289-93.
36 Dawson EB, Evans DR, Harris WA, Teter MC, McGanity WJ. The
effect of ascorbic acid supplementation on the blood lead levels of smokers.
Department of Obstetrics & Gynecology,
the University of Texas Medical Branch at Galveston, 77555-0587, USA. J Am
Coll Nutr. 1999 Apr;18(2):166-70.
37 Gamble J, Grewal PS, Gartside IB. Vitamin
C modifies the cardiovascular and microvascular responses to cigarette smoke
inhalation in man. School of Sport and Exercise Sciences, Birmingham University,
Birmingham B15 2TT, U.K. john.gamble@virgin.net Clin Sci (Lond).
2000 Apr;98(4):455-60.
38 Panda K, Chattopadhyay R, Ghosh MK, Chattopadhyay DJ, Chatterjee IB. Vitamin
C prevents cigarette smoke induced oxidative damage of proteins and increased
proteolysis. Dr. B. C. Guha Centre for Genetic Engineering and Biotechnology
and the Department of Biochemistry, University College of Science, Calcutta,
India. Free Radic
Biol Med. 1999 Nov;27(9-10):1064-79.
39 Hemila H, Douglas RM. Vitamin C and acute respiratory infections. Int J
Tuberc Lung Dis. 1999; 3:756-761.
40 Bucca C, Rolla G, Oliva A, Farina JC. Effect
of vitamin C on histamine bronchial responsiveness of patients with allergic
rhinitis. Dpt. di Scienze Biomediche e Oncologia Umana, Universita di Torino,
Italy. Ann Allergy. 1990 Oct;65(4):311-4.
41 Fortner BR Jr, Danziger RE, Rabinowitz PS, Nelson HS. The
effect of ascorbic acid on cutaneous and nasal response to histamine and allergen.
J Allergy Clin Immunol. 1982 Jun;69(6):484-8.
42 Cameron E, Pauling L. Supplemental
ascorbate in the supportive treatment of cancer: Prolongation of survival times
in terminal human cancer. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3685-9.
43 Moertel CG, Fleming TR, Creagan
ET, Rubin J, O'Connell MJ, Ames MM. High-dose
vitamin C versus placebo in the treatment of patients with advanced cancer
who have had no prior chemotherapy. A randomized double-blind comparison. N
Engl J Med. 1985 Jan 17;312(3):137-41.
44 Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, et al. Effects of high
dose vitamin C treatment on Helicobacter pylori ingestion and total vitamin
C concentration
in gastric juice. Eur J Cancer Prev. 1998; 7:449-454.
45 Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA,
Levine M. Vitamin
C pharmacokinetics: implications for oral and intravenous use. National Institute
of Diabetes and Digestive and Kidney Diseases, the National Cancer Institut,
and the Clinical Center, National Institutes of Health, Bethesda,
Maryland 20892-1372,
USA. Ann Intern Med. 2004 Apr 6;140(7):533-7.
46 Zhang HM, Wakisaka N, Maeda O, Yamamoto
T. Vitamin
C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter
pylori. Department of Infectious Disease and Tropical Medicine, Research Institute
International Medical Center of Japan, Tokyo. Cancer. 1997 Nov 15;80(10):1897-903.
47 Ip C. Interaction
of vitamin C and selenium supplementation in the modification of mammary carcinogenesis
in rats.
J Nat Cancer Inst. 1986; 77:299-303.
- Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, Colditz GA, Manson
JE, Hankinson SE, Willett WC. Dietary
carotenoids and vitamins A, C, and E and risk of breast cancer. Department
of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA. Shumin.Zhang@channing.harvard.edu
J Natl Cancer
Inst. 1999 Mar 17;91(6):547-56.
48 Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW.
Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin,
cisplatin,
and paclitaxel in human breast carcinoma cells in vitro. Department of Gynecology
and Obstetrics, University of Bonn Medical Center, Germany. Cancer Lett. 1996
Jun 5;103(2):183-9.
49 Harakeh S, Jariwalla RJ, Pauling L. Suppression
of human immunodeficiency virus replication by ascorbate in chronically and
acutely infected cells. Proc Natl Acad SciUSA. 1990; 87:7245-7249.
- Rivas CI, Vera JC, Guaiquil VH, et al. Increased
uptake and accumulation of Vitamin C in human immunodeficiency virus 1-infected
hematopoietic cell lines. J Biol Chem. 1997; 272:5814-5820.
50 Jacques PF, Chylack LT Jr, Hankinson SE, Khu PM, Rogers G, Friend J, Tung
W, Wolfe JK, Padhye N, Willett WC, Taylor A.
Long-term nutrient intake and early age-related nuclear lens opacities. Laboratory
for Nutrition and Vision, Jean Mayer US Department of Agriculture Human Nutrition
Research Center on Aging, Tufts University, 711 Washington
St, Boston, MA 02111,
USA. Arch Ophthalmol. 2001 Jul;119(7):1009-19.
51 Age-Related Eye Disease Study Research Group. A
randomized, placebo-controlled, clinical trial of high-dose supplementation
with vitamins C and E and beta carotene for age-related cataract and vision
loss:
AREDS report no. 9. Arch Ophthalmol. 2001 Oct;119(10):1439-52.
52 Simon JA, Hudes ES. Serum
ascorbic acid and other correlates of self-reported cataract among older Americans.
General Internal Medicine Section, Medical Service, Veterans Affairs Medical
Center, San Francisco, and University of California 94121, USA. jasimon@itsa.ucsf.edu
J Clin Epidemiol. 1999 Dec;52(12):1207-11.
53 Jacques PF. The
potential preventive effects of vitamins for cataract and age-related macular
degeneration. Jean Mayer-USDA Human Nutrition Research Center on Aging, Tufts
University Boston, USA. Int J Vitam Nutr Res. 1999 May;69(3):198-205.
54 Weinstein
M, Babyn P, Zlotkin S. An orange a day keeps the doctor away: scurvy in the
year 2000. Department of
Paediatrics, Hospital for Sick Children and University of Toronto, Toronto,
Canada. michael.weinstein@sickkids.on.ca
Pediatrics. 2001
Sep;108(3):E55.
55 Food and Nutrition Board, Institute of Medicine. Vitamin C. Dietary Reference
Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington D.C.:
National Academy Press; 2000:95-185. (National Academy Press)
- Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids.
Washington, D.C.: National Academy Press; 2000.
- Markham RG. Compositions and methods for administering vitamin C. United
States Patent Number 4, 822, 816.
April 18, 1989.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
|
Anti-Aging-Systeme
© 2008
|
Design by NB |